ALLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Allarity Therapeutics Inc (ALLR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, and no recent news or catalysts make it a hold. Additionally, the technical indicators and proprietary trading signals do not suggest a compelling entry point.
The MACD is slightly positive but contracting, RSI is neutral at 58.346, and moving averages are converging, indicating no clear trend. Key support is at 0.919, and resistance is at 1.087. The stock has a 40% chance to move -0.07% in the next day, 1.65% in the next week, and 3.74% in the next month.
NULL identified. No recent news or significant insider/hedge fund activity.
Poor financial performance in Q3 2025, with a significant drop in net income (-76.91% YoY) and EPS (-97.54% YoY). No recent congress trading data or news to suggest positive momentum.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -2,806,000 (-76.91% YoY), and EPS fell to -0.19 (-97.54% YoY). Gross margin remained at 0 with no improvement.
No analyst rating or price target changes available for evaluation.
